Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-03-17

Clinical Trial Update: Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating iron and vitamin E supplementation for disease activity in Crohn's disease and ulcerative colitis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iron supplement
  • Vitamin E supplement (tocopherol)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Crohn's Disease, Ulcerative Colitis | Phase 2 | Status: TERMINATED